Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 661 of 1,261
  1. US 9511039

    Enterically coated cysteamine, cystamine and derivatives thereof

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  2. US 9511020

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  3. US 9511015

    Methods and formulations for treating sialic acid deficiencies

    Ultragenyx Pharmaceutical Inc. · Granted Dec 6, 2016 · Expires Dec 1, 2036

    granted
  4. US 9505812

    Plasmodium falciparum antigens

    The United States of America as Represented bt the Secretary of the Navy · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  5. US 9504683

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  6. US 9505785

    Pyridone and aza-pyridone compounds and methods of use

    GILEAD CONNECTICUT, INC. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  7. US 9504736

    Administration of serine protease inhibitors to the stomach

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  8. US 9504745

    Compositions and methods for cancer treatment using targeted carbon nanotubes

    The Board of Regents of the University of Oklahoma · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  9. US 9505766

    Kinase inhibitors

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  10. US 9506926

    Molecular predictors of therapeutic response to specific anti-cancer agents

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  11. US 9506058

    Compositions for treating muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  12. US 9506041

    Delivery of packaged RNA to mammalian cells

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  13. US 9505826

    Modified antibody with improved half-life

    TEVA PHARMACEUTICALS AUSTRALIA PTY LTD · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  14. US 9505781

    Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  15. US 9504664

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  16. US 9504729

    Antiangiogenic small molecules and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  17. US 9506922

    Methods for producing an immune response to tuberculosis

    United States Government as represented by the Department of Veterans Affairs · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  18. US 9506032

    Engineered biological pacemakers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  19. US 9506040

    Prevascularized constructs for implantation to provide blood perfusion

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  20. US 9506056

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Northwestern University · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  21. US 9506067

    Compositions and methods for inhibiting expression of the HAMP gene

    Alnylam Pharmaceuticals, Inc. · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  22. US 9505809

    Proteins with repetitive bacterial-IG-like (BIG) domains present in Leptospira species

    The Regents of the University of California · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  23. US 9505782

    Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted
  24. US 9505778

    Monomers, polymers and articles containing the same from sugar derived compounds

    Regents of the University of Minnesota · Granted Nov 29, 2016 · Expires Nov 24, 2036

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.